Iwqol-lite-ct Today

Scoring is performed by reverse‑coding (higher scores reflect QoL) and linearly transforming each domain to a 0–100 metric.

The is a 20-item patient-reported outcome (PRO) measure specifically designed to evaluate the physical and psychosocial effects of weight on adults in clinical trial settings. Overview and Purpose iwqol-lite-ct

All psychometric studies were conducted in compliance with the guidelines (COnsensus‑based Standards for the selection of health Measurement INstruments). iwqol-lite-ct

[ \textDomain Score = \frac\text(Raw – Minimum)\text(Maximum – Minimum) \times 100 ] iwqol-lite-ct

| Trial Phase | Objective | Example Endpoints | |-------------|-----------|-------------------| | | Proof‑of‑concept for weight‑loss pharmacotherapy | Change in IWQOL‑Lite‑CT Total at Week 12 | | Phase III | Pivotal efficacy & safety | Proportion of participants achieving ≥7‑point improvement | | Post‑marketing / RWE | Long‑term QoL monitoring | Trajectory of domain scores over 2 years | | Device trials (e.g., gastric balloons) | Comparative QoL benefit vs. standard care | Difference in Physical Function change at 6 months |

| Score Range | Interpretation | |-------------|----------------| | 80–100 | Mild or no impact of weight on QoL | | 60–79 | Moderate impact | | 40–59 | Severe impact | | 0–39 | Very severe impact |

The IWQOL-Lite-CT consists of 20 items distributed across two core domains: